Skip to content
Open access

Loss of BCAP31 or POLR1E Accelerates Aging in C. elegans and is Linked to Senescence in Vascular Endothelium

Aug 2026 · Advances in Biology · Vol 10 · 0 citations · 46 references
Medicine

TL;DR

These findings establish BCAP31 and POLR1E as evolutionarily conserved components of a CD44‐associated network that protects against cellular senescence and organismal aging, highlighting new potential targets for mitigating age‐related vascular decline.

Abstract

Aging involves the progressive decline of cellular function, yet the key molecular regulators that determine aging require further identification. Building on our previous finding that the intracellular domain of CD44 (CD44ICD) is a critical aging regulator, we performed an interactome screen to identify its functional partners. This approach revealed BCAP31 and POLR1E as two previously unrecognized modulators of senescence. Depletion of their respective orthologs in Caenorhabditis elegans (C. elegans) shortened lifespan and accelerated age‐related functional decline. In human vascular endothelial cells, knockdown of BCAP31 or POLR1E induced premature cellular senescence, whereas their overexpression countered it. Importantly, the protein levels of both BCAP31 and POLR1E decreased during physiological aging across species, including in senescent endothelial cells, aged nematodes, and tissues from old mice, with BCAP31 reduction being particularly pronounced in the cardiovascular system. Our findings establish BCAP31 and POLR1E as evolutionarily conserved components of a CD44‐associated network that protects against cellular senescence and organismal aging, highlighting new potential targets for mitigating age‐related vascular decline.

Read PDF

Similar papers

Open access Sep 2026

Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging

Findings support a model in which endothelial senescence contributes to vascular dysfunction and systemic aging mediated by C/EBPβ/AEP signaling, and establish C/EBPβ/AEP as a therapeutic target to preserve vascular integrity and mitigate systemic frailty in aging populations.

Bo-Wei Li, Shu-Ke Nie, Meng-Meng Wang et al. · 0 citations
Open access Aug 2026

CK2α restriction of STING accumulation underlies systemic aging

This work identifies lamin A/C (LMNA) as a critical NE scaffold that orchestrates STING regulation by recruiting both STING and Casein Kinase 2 (CK2α), and establishes the LMNA-CK2-STING axis as a key biochemical mechanism that suppresses innate immune activation at the NE.

Jie Zhang, Mei-Ling Jin, Dan Rao et al. · 0 citations
Open access Sep 2026

CBX4 stabilizes NEUROD1 through SUMO-ubiquitin crosstalk to delay β-cell senescence

Aging-associated β-cell senescence is a key driver of type 2 diabetes mellitus (T2DM). However, its associated molecular mechanisms remain poorly explored. This study identifies Chromobox 4 (CBX4), a Polycomb group protein with SUMO E3 ligase activity, as an essential regulator of β-cell aging and function. The results...

Lin-Min Su, Yan Liu, Qian-Xing Hu et al. · 0 citations
Open access Sep 2026

Age-Associated YBX1 Phosphorylation Regulates the Keratinocyte Senescence-Associated Secretory Phenotype Through Translational Control

Skin aging is characterized by epidermal atrophy, reduced keratinocyte proliferation, and the accumulation of senescent cells that sustain a chronic, low-grade inflammatory secretome known as the senescence-associated secretory phenotype (SASP). We previously showed that Y-box binding protein 1 (YBX1) limits keratinocy...

Valdi Ven Japranata, Michelle Liu, F. Boncimino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.